Analysis of Frailty Syndrome in Patients
Analysis of the Pathophysiology of Frailty Syndrome and Clinical Development of Frailty Within the Framework of the Innovation Fund Project PRÄP-GO (ANA-PRÄP-GO)
This study is trying to better understand frailty syndrome by looking at different aspects of it in patients who are frail, along with a control group of non-frail patients and their family members.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1640 (estimated) |
| Ages | 70 Years and up |
| Sex | All |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 27 sites (Schwante, Brandenburg and 26 other locations) |
| Trial ID | NCT04880824 on ClinicalTrials.gov |
What this trial studies
This study aims to characterize and phenotype frailty syndrome through a comprehensive observational approach. Participants will include patients with frailty from the PRÄP-GO intervention study, a non-frail surgical control group, and a non-surgical comparison group. The study will evaluate various clinical, psychosocial, and pathophysiological aspects related to frailty. Additionally, relatives of patients may also participate, contributing to a broader understanding of the condition.
Who should consider this trial
Good fit: Ideal candidates include patients aged 70 and older scheduled for elective surgery who do not exhibit frailty syndrome.
Not a fit: Patients with severe cardiac or pulmonary diseases, moribund conditions, or significant neuropsychiatric impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and treatment strategies for frailty syndrome, enhancing patient outcomes.
How similar studies have performed: While there have been studies on frailty, this specific approach of detailed characterization within a multimodal intervention framework is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
PG cohort: Inclusion criteria * Consent given and inclusion in PRÄP-GO * Patient capable of giving consent or existing legal guardian in the case of patients not capable of giving consent Exclusion criteria - None NFC cohort: Inclusion criteria * Patient capable of giving consent or existing legal guardian in the case of patients not capable of giving consent * Age ≥ 70 years * Elective surgery planned * Expected anesthesia duration\> 60 min * No frailty syndrome (0 positive out of 5 standardized parameters) according to the physical frailty phenotype (Fried et al., 2001) Exclusion criteria * Severe cardiac or pulmonary disease (NYHA IV, Gold IV) * Intracranial interventions * Moribund patients (palliative situation) * Patients with a neuropsychiatric clinical picture or severe hearing and / or visual acuity impairment (not compensated by visual or hearing aids), which limit the performance of the neurocognitive tests * Insufficient language skills * Participation in another interventional rehabilitation study or a study according to the German Drug Law or the medical Device Law that has not been approved by the study leader (Exception: parallel participation in adjuvant therapy study). NO cohort: Inclusion criteria - Age ≥ 70 years * No elective surgery planned * No surgery within 6 months prior to study enrollment Exclusion criteria - See NFC cohort GB cohort: Inclusion criterion - Doctor, nurse or therapist from the cooperation partners of PRAEP-GO who were involved in the project Exclusion criterion - Language barrier Relatives: Inclusion criteria * Member of a patient in the PRÄP-GO cohort * Age ≥ 18 years Exclusion criterion - Language barrier
Where this trial is running
Schwante, Brandenburg and 26 other locations
- Praxis Prof. Dr med. Ulrich Schwantes — Schwante, Brandenburg, Germany (Recruiting)
- Charité-Universitätsmedizin Berlin, Department of Physical Medicine — Berlin, Germany (Recruiting)
- Praxis Landgraf — Berlin, Germany (Recruiting)
- Department of Anesthesiology and Operative Intensive Care Medicine (CBF) — Berlin, Germany (Recruiting)
- Department of Anesthesiology and Intensive Care Medicine, Charité - University Medicine — Berlin, Germany (Recruiting)
- Paul Gerhard Diakonie - Evangelisches Waldkrankenhaus Spandau — Berlin, Germany (Not_yet_recruiting)
- Paul Gerhard Diakonie - Evangelisches Krankenhaus Hubertus — Berlin, Germany (Recruiting)
- Paul Gerhard Diakonie - Martin-Luther-Krankenhaus — Berlin, Germany (Not_yet_recruiting)
- Auguste-Viktoria-Klinikum - Vivantes - Netzwerk für Gesundheit GmbH — Berlin, Germany (Recruiting)
- CARITAS Klinik Maria Heimsuchung — Berlin, Germany (Recruiting)
- Dominikus-Krankenhaus — Berlin, Germany (Recruiting)
- Humboldt-Klinikum - Vivantes - Netzwerk für Gesundheit GmbH — Berlin, Germany (Not_yet_recruiting)
- Klinikum im Friedrichshain - Vivantes - Netzwerk für Gesundheit GmbH — Berlin, Germany (Not_yet_recruiting)
- Sankt Jospeph Krankenhaus — Berlin, Germany (Recruiting)
- Unfallkrankenhaus Berlin — Berlin, Germany (Not_yet_recruiting)
- Universitätsklinikum Mannheim GmbH — Berlin, Germany (Not_yet_recruiting)
- Wenckebach-Klinikum - Vivantes - Netzwerk für Gesundheit GmbH — Berlin, Germany (Not_yet_recruiting)
- Carl-Thiem-Klinikum — Cottbus, Germany (Not_yet_recruiting)
- Werner Forßmann-Krankenhaus — Eberswalde, Germany (Not_yet_recruiting)
- Klinikum Frankfurt Oder GmbH — Frankfurt/Oder, Germany (Not_yet_recruiting)
- Universitätsklinikum Hamburg-Eppendorf — Hamburg, Germany (Not_yet_recruiting)
- Asklepios Klinikum Harburg — Harburg, Germany (Not_yet_recruiting)
- Sana Kliniken Sommerfeld — Kremmen, Germany (Recruiting)
- Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Universität zu Lübeck — Lübeck, Germany (Not_yet_recruiting)
- Klinikum der Universität München, LMU Campus Großhadern — München, Germany (Not_yet_recruiting)
- Klinikum rechts der Isar - Technische Universität München — München, Germany (Not_yet_recruiting)
- München Klinik Bogenhausen — München, Germany (Not_yet_recruiting)
Study contacts
- Study coordinator: Claudia Spies, MD, Prof.
- Email: claudia.spies@charite.de
- Phone: +49 30 450 551102
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.